Menu

eFFECTOR Therapeutics, Inc. EFTR

Full chart Compare
Set alert

Price alert · EFTR

All alert types
0.00 USD 0.00 (+300.00%)

At closeNov 5, 2026, 4:00 PM EST

0.0002 Day range 0.0002
0.0002 52-week range 0.01
YTD
+300.00%
1 year
+300.00%

Revenue & Expenses

Other Income → Expenses: $11.99MExpenses → Selling, General & Admin: $12.64MExpenses → Research & Development: $23.31MExpenses → Interest Expense: $2.25MGross Profit → Expenses: $3.55MRevenue → Gross Profit: $3.55MNet Loss → Expenses: $22.66MOther Income$11.99MGross Profit$3.55MNet Loss$22.66MExpenses$38.21MSelling, General & Admin$12.64MResearch & Development$23.31MInterest Expense$2.25MRevenue$3.55M

Latest period ending Dec 31, 2023 · select a line to chart its full history

EFTR annual income statement
Fiscal yearFY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019
-33.84M-32.40M-31.90M15.82M-28.61M
-35.81M-22.66M15.80M14.21M-29.74M
-16.37-13.7611.002.75-28.75
EFTR annual balance sheet
Fiscal yearFY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019
14.88M8.71M49.70M15.22M3.43M
20.54M29.08M54.06M16.70M5.09M
26.34M25.18M36.77M15.72M18.93M
20.55M20.28M20.03M12.96M15.24M
-5.79M3.90M17.28M-132.25M-147.06M
EFTR annual cash flow
Fiscal yearFY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019
-29.55M-25.90M-24.89M13.84M-27.60M
14.48M-17.86M565.00K-154.00K84.00K
21.23M2.77M58.81M-1.89M20.24M
-97.00K-192.00K565.00K-154.00K84.00K
6.17M-40.99M34.49M11.79M-7.27M